Learning Objectives

At the end of the session, participants will be able to:

• Counsel women on the benefits and risks of hormone therapy based on the latest scientific information;
• Offer an individualized approach to therapy based on personal preferences and established risk factors.

Faculty

• Robert Gauthier, MD (Moderator), Mont Royal, QC
• Robert Reid, MD, Kingston, ON
• Michelle Warren, MD, New York, NY

Unrestricted Educational Grants

• Wyeth Pharmaceuticals

Learning Objectives

At the end of the session, participants will be able to:

• Identify the prevailing sexual passages through a woman's lifespan;
• Relate these stages to hormonal changes and other physiological modifiers;
• Appreciate the impact of chronic illness and other physical limitations on healthy sexuality;
• Identify appropriate investigations for the evaluation of female sexual dysfunctions;
• Examine available treatment options for female sexual dysfunctions.

Faculty

• Robert Lea, MD (Moderator), Glen Haven, NS
• Nathalie Gamache, MD, Orleans, ON
• Sandra Leiblum, PhD, Piscataway, NJ

Unrestricted Educational Grants

• Bayer HealthCare Pharmaceuticals

Learning Objectives

At the end of the session, participants will be able to:

• Review the cellular histopathology of persistent trophoblastic neoplasia;
• Update the staging and nomenclature of GTN, including FIGO/WHO 2002;
• Review the changes in hGC testing, particularly with regard to H-hCG and the diagnosis and management of phantom and quiescent hCG syndromes;
• Review the evolution of management strategies for GTN, particularly low-risk disease;
• Reiterate the need for regional management of GTN by a very few knowlegable oncologists;
• Review the epidemiology of the disease.

Faculty

• Paula Victoria Rittenberg, MD (Moderator), Halifax, NS
• Alon Altman, MD, Winnipeg, MB
• Raymond Osborne, MD, Toronto, ON

Unrestricted Educational Grants

• Society of Obstetricians and Gynaecologists of Canada

Learning Objectives

At the end of the session, participants will be able to:

• Review current guidelines for screening, glucose monitoring and glycemic/obstetric management of Gestational Diabetes (GDM);
• Understand preconceptual counseling parameters and pregnancy care recommendations for women with pre-existing diabetes mellitus;
• Discuss timing and mode of delivery in women with GDM and pre-existing diabetes;
• Evaluate the evidence for the use of hypoglycemic agents in the management of GDM and pre-existing diabetes;
• Consider the indications and dosage recommendations for insulin therapy in GDM and insulin-pump therapy in pre-existing diabetes in the prenatal, intra-partum and postpartum periods;
• Assess current recommendations for management of women with impaired glucose tolerance in pregnancy.

Faculty

• Anthony Armson, MD (Course Director), Halifax, NS
• Thomas Ransom, MD, Halifax, NS

Learning Objectives

At the end of the session, participants will be able to:

• Understand the systematic interpretation of EFM;
• Understand some of the fetal physiology causing EFM pattern changes;
• Understand the definitions of EFM patterns;
• Become familiar with current EFM nomenclature in Canada.

Faculty

• William Ehman, MD (Course Director), Nanaimo, BC

Learning Objectives

At the end of the session, participants will be able to:

• Become aware of the CMPA experience with VBAC and how this should affect practice;
• List the optimal content of an informed consent discussion for attempting VBAC;
• List factors which indicate an increased or decreased chance of: Success in achieving VBAC, Uterine rupture during attempted VBAC;
• List the resources of personnel and equipment that should be available for the prudent conduct of a trial of labour.

Faculty

• Douglas Bell, MD (Course Director), Ottawa, ON
• George Carson, MD, Regina, SK

Learning Objectives

At the end of the session, participants will be able to:

• Describe strategies to optimize induction rate;
• Offer alternatives for the unfavorable cervix;
• Understand the management of post date and post term pregnancies.

Faculty

• Lucie Morin, MD,FRCSC (Course Director), Outremont, QC
• N. Lynne McLeod, MD, Halifax, NS

Learning Objectives

At the end of the session, participants will be able to:

• Describe indications and method for external version;
• List circumstances under which vaginal breech delivery is acceptable;
• Describe the prerequisites for vaginal breech delivery;
• List recommendations to obtain informed consent for vaginal breech delivery.

Faculty

• Robert Gagnon, MD (Course Director), Verdun, QC

Learning Objectives

At the end of the session, participants will be able to:

• Review the indications for surgery in women with infertility;
• Discuss alternatives for women with endometriosis and infertility;
• Compare the role of ART and laparoscopy for fertility enhancement.

Faculty

• Gillian Graves, MD (Course Director), Halifax, NS
• Sukhbir Singh, MD,FRCSC (Course Director), Ottawa, ON

Learning Objectives

At the end of the session, participants will be able to:

• Examine the significant tax advantages available to a medical practitioner who derives income through a professional corporation rather than directly from a practice operated in his or her name;
• Withdraw funds from their corporation through salary and/or dividends;
• Accumulate income for retirement through a Registered Retirement Savings, an individual Pension Plan or through retaining income inside their professional corporation;
• Structure insurances in a tax-efficient manner;
• Plan opportunities to reduce future income taxes and probate fees on the value of a medical professional's estate.

Faculty

• Diane Gagne, VAC, PLFin, RLU, CFP (Course Director), Gatineau, QC
• John Vachon, RHU, Gatineau, QC

Learning Objectives

At the end of the session, participants will be able to:

• Discuss the different methods available for cervical preparation;
• Describe the D&C technique;
• Describe the dilation and evacuation (D&E) technique;
• Know the complications associated with each procedure.

Faculty

• Marie-Soleil Wagner, MD,FRCSC (Course Director), Verdun, QC

Learning Objectives

At the end of the session, participants will be able to:

• Review the appropriate use of prophylactic antibiotics in gynaecologic surgery and procedures;
• Discuss pre-operative screening and treatment of bacterial vaginosis prior to hysterectomy;
• Review antibiotic therapy for pelvic inflammatory disease.

Faculty

• Julie van Schalkwyk, MD (Course Director), Vancouver, BC
• Eliana Castillo, MD, Calgary, AB

Learning Objectives

At the end of the session, participants will be able to:

• Ensure that health care providers are familiar with various contraceptive options including indications, contra-indications and efficacy;
• Effectively troubleshoot common challenges associated with contraceptive use;
• Choose the most appropriate contraceptive options for patients with various medical conditions;
• Discuss recent findings in the contraceptive literature.

Faculty

• Robert Reid, MD (Course Director), Kingston, ON
• Amber Lynn Whitford, MD, Red Deer, AB

Learning Objectives

At the end of the session, participants will be able to:

• Use medical software such as a drug database to find required information;
• Find and download "Podcasts" with medical information;
• Set up a personal website using the SOGC.

Faculty

• Karen Glass, MD (Course Director), Toronto, ON

Learning Objectives

At the end of the session, participants will be able to:

• Identify factors impacting on bone health, diagnosis of bone loss, and therapy outcomes;
• Understand recent discoveries about bone biology, particularly as they relate to osteoclast biology, and their potential impact on the management of bone loss;
• Differentiate the mechanisms of action agents targeting the RANK/RANKL/OPG pathway in bone loss from currently available treatment options;
• Evaluate and summarize efficacy and safety data on current and emerging treatment options for the prevention and therapy of bone loss associated with osteoporosis.

Faculty

• Garry Krepart, MD (Moderator), Winnipeg, MB
• J.D. Adachi, MD, Hamilton, ON
• Michael McClung, MD, Portland, OR
• Nelson Watts, MD, Cincinnati, OH

Unrestricted Educational Grants

• AMGEN Canada Inc.

Learning Objectives

At the end of the session, participants will be able to:

• Discuss the international evidence for the importance of health determinants in practice;
• Describe clinical situations where health determinants will influence the diagnosis and treatment of disease;
• Propose actions to promote and apply health determinants in every day clinical practice.

Faculty

• J. Kenneth Milne, MD (Moderator), London, ON
• Jennifer Blake, MD, Toronto, ON
• Dawn Walker, RN, Ottawa, ON

Unrestricted Educational Grants

• Schering Plough Canada Inc.